Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed Sep 9, 2019
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Award
Options (Right to Buy)
2019-09-05+35,433→ 35,433 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (35,433 underlying) - Award
Options (Right to Buy)
2019-09-05+39,567→ 39,567 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (39,567 underlying)
Footnotes (2)
- [F1]Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.
- [F2]The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.